Literature DB >> 19516278

Development of fiber-substituted adenovirus vectors containing foreign peptides in the adenovirus serotype 35 fiber knob.

H Matsui1, F Sakurai, S Kurachi, K Tashiro, K Sugio, K Kawabata, K Yamanishi, H Mizuguchi.   

Abstract

Fiber-substituted adenovirus (Ad) vectors containing fibers of Ad serotype 35 (AdF35) efficiently transduce a variety of human cells because their receptor, human CD46, is ubiquitously expressed on almost all nucleated cells. However, the ubiquitous expression of CD46 might lead to unexpected transduction in untargeted organs. In this study, we developed fiber-modified AdF35 vectors with an integrin-binding Arg-Gly-Asn (RGD) peptide incorporated into the FG, HI or IJ loop, which have been identified as important regions for binding to CD46. Incorporation of foreign peptides into these loops does not inhibit trimerization of the fibers. In CD46-negative cells, fiber-mutant AdF35 vectors containing an RGD peptide in the FG or HI loop showed 6- to 30-fold higher transduction efficiencies in an RGD-peptide-dependent manner than the unmodified AdF35 vectors. In contrast, in CD46-positive cells, insertion of foreign peptides markedly reduced the transduction efficiencies of the AdF35 vectors, indicating that insertion of foreign peptides significantly inhibits binding to CD46. In particular, CD46-mediated transduction was completely diminished by insertion of foreign peptides into the HI loop. Our findings indicate that HI loop is the most suitable domain to mediate a foreign peptide-dependent and CD46-independent transduction by incorporation of foreign peptides into the Ad35 fiber knob.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19516278     DOI: 10.1038/gt.2009.65

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  6 in total

Review 1.  A novel fiber chimeric conditionally replicative adenovirus-Ad5/F35 for tumor therapy.

Authors:  Ming Yang; Chun Sheng Yang; WenWen Guo; JianQin Tang; Qian Huang; ShouXin Feng; AiJun Jiang; XiFeng Xu; Guan Jiang; Yan Qun Liu
Journal:  Cancer Biol Ther       Date:  2017-11-16       Impact factor: 4.742

Review 2.  Prospects for oral replicating adenovirus-vectored vaccines.

Authors:  Cailin Deal; Andrew Pekosz; Gary Ketner
Journal:  Vaccine       Date:  2013-05-22       Impact factor: 3.641

3.  Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures.

Authors:  Aleksei A Stepanenko; Anastasiia O Sosnovtseva; Marat P Valikhov; Anastasia A Chernysheva; Sergey A Cherepanov; Gaukhar M Yusubalieva; Zsolt Ruzsics; Anastasiia V Lipatova; Vladimir P Chekhonin
Journal:  Mol Ther Oncolytics       Date:  2021-12-21       Impact factor: 7.200

4.  An inactivated novel chimeric FAdV-4 containing fiber of FAdV-8b provides full protection against hepatitis-hydropericardium syndrome and inclusion body hepatitis.

Authors:  Baiyu Wang; Mingzhen Song; Congcong Song; Shiyi Zhao; Panpan Yang; Qilong Qiao; Yanfang Cong; Yanling Wang; Zeng Wang; Jun Zhao
Journal:  Vet Res       Date:  2022-09-30       Impact factor: 3.829

5.  Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon.

Authors:  Xingui Tian; Xiaobo Su; Xiao Li; Haitao Li; Ting Li; Zhichao Zhou; Tianhua Zhong; Rong Zhou
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

6.  Fiber modifications enable fowl adenovirus 4 vectors to transduce human cells.

Authors:  Wenfeng Zhang; Xiaojuan Guo; Fengcai Yin; Xiaohui Zou; Wenzhe Hou; Zhuozhuang Lu
Journal:  J Gene Med       Date:  2021-06-11       Impact factor: 4.565

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.